EP11.03-08 Multicenter Pharmacokinetic Study of Pembrolizumab for Non-Small Cell Lung Cancer in Older Adults Aged Over 75 Years.

MLA

Horinouchi, H., et al. “EP11.03-08 Multicenter Pharmacokinetic Study of Pembrolizumab for Non-Small Cell Lung Cancer in Older Adults Aged Over 75 Years.” Journal of Thoracic Oncology, vol. 18, no. 11, Nov. 2023, p. S622. EBSCOhost, https://doi.org/10.1016/j.jtho.2023.09.1180.

APA

Horinouchi, H., Ohe, Y., Yamanaka, Y., Kurata, T., Watanabe, K., Hosomi, Y., Nakahara, Y., Asao, T., Saeki, S., Tsubata, Y., Fujita, Y., Konishi, J. S., Mizugaki, H., Ohuchi, M., Yagishita, S., & Hamada, A. (2023). EP11.03-08 Multicenter Pharmacokinetic Study of Pembrolizumab for Non-Small Cell Lung Cancer in Older Adults Aged Over 75 Years. Journal of Thoracic Oncology, 18(11), S622. https://doi.org/10.1016/j.jtho.2023.09.1180

Chicago

Horinouchi, H., Y. Ohe, Y. Yamanaka, T. Kurata, K. Watanabe, Y. Hosomi, Y. Nakahara, et al. 2023. “EP11.03-08 Multicenter Pharmacokinetic Study of Pembrolizumab for Non-Small Cell Lung Cancer in Older Adults Aged Over 75 Years.” Journal of Thoracic Oncology 18 (11): S622. doi:10.1016/j.jtho.2023.09.1180.